Update on the Proposed TRIPS Waiver at the WTO: Where is it Headed, and What to Expect?

Published date08 June 2021
Subject MatterTrade Secrets,WTO,Copyright,Waivers,Bilateral Investment Treaties,USTR,Tucker Act,Vaccinations,Industrial Design,TRIPS Agreement,Pharmaceutical Patents,Intellectual Property Protection,Pharmaceutical Industry,Takings Clause,United States-Mexico-Canada Agreement (USMCA),Coronavirus/COVID-19
AuthorJeffrey Telep,Daniel Crosby,Brian White,Evan Diamond,Jamieson Greer,Isabel Fernandez de la Cuesta
Law FirmKing & Spalding

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT